The Impact of COVID-19 on Outpatient Intravenous Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers (POICs)
SUGAR LAND, TX – (February 16, 2022) The coronavirus disease 2019 (COVID-19) pandemic dramatically affected the provision of healthcare in the U.S. with sharp declines in routine and elective healthcare services. A study evaluated how COVID-19 impacted the provision...
A 3-Year Evaluation of Antibiotic Resistance Patterns in Gram-Negative Genitourinary Tract Infections Treated in Outpatient Infusion Centers (POICs)
SUGAR LAND, TX – (February 16, 2022) Resistant Gram-negative pathogens (GNP) are a primary cause of many infections, particularly genitourinary tract infections (GUI). High recurrence rates and increasing antibiotic resistance often require intravenous antibiotics...
Healix Infusion Therapy and Collaborators Publish Real-World Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study
SUGAR LAND, TX – (March 20, 2020) Healix Infusion Therapy, LLC, announced today the publication of a collaborative study in the leading scientific journal, Open Forum Infectious Diseases. This real-world multicenter study demonstrated successful prevention of...
Recent Comments